Lattke, Michael https://orcid.org/0000-0001-5533-8592
Tan, Wee Leng https://orcid.org/0009-0007-4977-8656
Sukumaran, Salil Kalarikkal
Utami, Kagistia Hana
Sintes, Marcos
Sakthivel, Srinivasan
Tan, Jonathan https://orcid.org/0009-0005-5105-7853
Lim, Auriel
Bansal, Vibhavari Aysha https://orcid.org/0000-0002-9745-3633
Rekopoulou, Katerina
Matthews, Nik https://orcid.org/0000-0002-0602-1131
Alić, Ivan https://orcid.org/0000-0002-8125-8198
Krsnik, Željka
Nižetić, Dean https://orcid.org/0000-0001-5486-5761
Levi, Boaz P. https://orcid.org/0000-0002-8346-872X
De Paola, Vincenzo https://orcid.org/0000-0001-9987-8291
Funding for this research was provided by:
RCUK | Medical Research Council (MR/V034529/1)
Wellcome Trust (217199/Z/19/Z)
Hrvatska Zaklada za Znanost (HRZZ-IP-2022-10-5975)
Article History
Received: 8 October 2025
Accepted: 9 January 2026
First Online: 16 January 2026
Competing interests
: A patent application has been filed related to antisense oligonucleotide targets identified in this study (V.D.P. and M.L.). The other authors declare no competing interests.